hMSC

BIOLOGICAL2 trials

Sponsors

Stemedica Cell Technologies, Inc., Bernard (Barry) Baumel

Conditions

Agitation in DementiaAlzheimer DiseaseCovid19

Phase 2

A Phase II Study in Patients With Moderate to Severe ARDS Due to COVID-19

Stemedica Cell Technologies, Inc.Covid19

Start: 2021-03-20End: 2022-12-31Target: 40Updated: 2022-07-08

Human Mesenchymal Stem Cells (hMSC) in Behavioral Problems Due to Alzheimer's Disease.

RecruitingNCT06781333

Bernard (Barry) BaumelAgitation in Dementia, Alzheimer Disease

Start: 2025-04-29End: 2027-12-15Target: 8Updated: 2026-05-28